{"id":"https://openalex.org/W3135328828","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","title":"PI3K/AKT pathway biomarkers analysis from the phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic castration-resistant prostate cancer.","display_name":"PI3K/AKT pathway biomarkers analysis from the phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic castration-resistant prostate cancer.","publication_year":2021,"publication_date":"2021-02-20","ids":{"openalex":"https://openalex.org/W3135328828","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","mag":"3135328828"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.6_suppl.13","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. De Bono","raw_affiliation_strings":["The Institute of Cancer Research and the Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and the Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Sweeney","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061095811","display_name":"Sergio Bracarda A","orcid":"https://orcid.org/0000-0002-0703-2959","observed_orcids":["https://orcid.org/0000-0002-0703-2959"]},"institutions":[{"id":"https://openalex.org/I4210123105","display_name":"Azienda Ospedaliera S.Maria","ror":"https://ror.org/02t96cy48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123105"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sergio Bracarda","raw_affiliation_strings":["Azienda Ospedaliera S. Maria, Terni, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Ospedaliera S. Maria, Terni, Italy;","institution_ids":["https://openalex.org/I4210123105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004985848","display_name":"Cora Nanette Sternberg","orcid":"https://orcid.org/0000-0003-3938-2627","observed_orcids":["https://orcid.org/0000-0003-3938-2627"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cora N. Sternberg","raw_affiliation_strings":["Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY;","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005231494","display_name":"Kim N. Chi","orcid":"https://orcid.org/0000-0002-3782-7226","observed_orcids":["https://orcid.org/0000-0002-3782-7226"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kim N. Chi","raw_affiliation_strings":["BC Cancer Agency, Vancouver, BC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency, Vancouver, BC, Canada;","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Olmos","raw_affiliation_strings":["Spanish National Cancer Research Center (CNIO), Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Spanish National Cancer Research Center (CNIO), Madrid, Spain;","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shahneen Kaur Sandhu","raw_affiliation_strings":["Peter MacCallum Cancer Center, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Center, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090082356","display_name":"Christophe Massard","orcid":"https://orcid.org/0000-0001-5505-0564","observed_orcids":["https://orcid.org/0000-0001-5505-0564"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Massard","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014625956","display_name":"Nobuaki Matsubara","orcid":"https://orcid.org/0000-0002-9203-4245","observed_orcids":["https://orcid.org/0000-0002-9203-4245"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuaki Matsubara","raw_affiliation_strings":["National Cancer Center Hospital East, Chiba, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital East, Chiba, Japan;","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042329751","display_name":"Josep Garcia","orcid":"https://orcid.org/0000-0002-0849-1698","observed_orcids":["https://orcid.org/0000-0002-0849-1698"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Josep Garcia","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091194323","display_name":"Ma\u0142gorzata Nowicka","orcid":"https://orcid.org/0000-0002-5918-5981","observed_orcids":["https://orcid.org/0000-0002-5918-5981"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Malgorzata Nowicka","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001032099","display_name":"Matthew J. Wongchenko","orcid":"https://orcid.org/0000-0003-1230-7117","observed_orcids":["https://orcid.org/0000-0003-1230-7117"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Wongchenko","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102027405","display_name":"Zhen Shi","orcid":"https://orcid.org/0009-0005-8502-7978","observed_orcids":["https://orcid.org/0009-0005-8502-7978","https://orcid.org/0000-0001-7560-1810"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhen Shi","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"6_suppl","first_page":"13","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipatasertib","display_name":"ipatasertib","score":0.847000002861023},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.890999972820282},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9779999852180481},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6389999985694885},{"id":"https://openalex.org/keywords/radiographic-progression-free-survival","display_name":"radiographic progression-free survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tumor-genomic-alterations","display_name":"tumor genomic alterations","score":0.6800000071525574},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5590000152587891},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.49399998784065247},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.36899998784065247},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.9649561643600464},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8208416700363159},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.698622465133667},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5751590728759766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5144405961036682},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4960344731807709},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4424275755882263},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4412410259246826},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.4291127920150757},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3609279990196228},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3452910780906677},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.21602961421012878},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.08885279297828674},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08008766174316406},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.6_suppl.13","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.6_suppl.13","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2588340304","https://openalex.org/W4407003789","https://openalex.org/W4286296187","https://openalex.org/W3008542548","https://openalex.org/W3180644743","https://openalex.org/W3201850473","https://openalex.org/W2884876277","https://openalex.org/W3088602042","https://openalex.org/W2761902517","https://openalex.org/W2890219413"],"abstract_inverted_index":{"13":[0],"Background:":[1],"In":[2,63,263],"IPATential150":[3],"(NCT03072238),":[4],"ipatasertib":[5],"(ipat)":[6],"+":[7,31,85,96,204,266,306,317,343,367],"abiraterone":[8],"(abi)":[9],"as":[10,136,369],"first-line":[11,374],"treatment":[12,371],"for":[13,23,120,373],"metastatic":[14],"castration-resistant":[15],"prostate":[16],"cancer":[17],"(mCRPC)":[18],"significantly":[19],"reduced":[20],"the":[21,56,165,193,199,294,361],"risk":[22],"disease":[24],"worsening":[25],"or":[26],"death":[27],"vs":[28,202],"placebo":[29],"(pbo)":[30],"abi":[32,86,205,267,307,344,368],"in":[33,55,274,332],"patients":[34,64],"(pts)":[35],"with":[36,38,65,83,94,107,142,160,198,223,271,276,304,315,323,325,329,341,347,358,376,383],"tumors":[37,68,281,324],"PTEN":[39,66,121,125,132,187,209,224,277,326],"loss":[40,67,122,133,210,327],"by":[41,69,123,179,192,211,279],"immunohistochemistry":[42],"(IHC;":[43],"HR,":[44,226,234,242,250,257,288],"0.77":[45],"[95%":[46,228,236,244,252,259,290],"CI:":[47,80,91,291,301,312],"0.61,":[48],"0.98];":[49],"P":[50],"=":[51,130,176,184],"0.0335)":[52],"but":[53],"not":[54,269],"intention-to-treat":[57],"population":[58],"(de":[59],"Bono,":[60],"ESMO":[61],"2020).":[62],"IHC,":[70],"median":[71,295],"radiographic":[72],"progression-free":[73],"survival":[74],"(rPFS)":[75],"was":[76,134,190,206,213,268,297],"16.5":[77],"mo":[78,89,299,310],"(95%":[79,90,300,311],"13.9,":[81],"17.0)":[82],"pbo":[84,203,305],"and":[87,308,328],"18.5":[88],"16.3,":[92],"22.1)":[93],"ipat":[95,265,316,342,366],"abi.":[97,318],"Here,":[98],"we":[99],"present":[100],"exploratory":[101],"analyses":[102],"evaluating":[103],"putative":[104],"biomarker":[105],"associations":[106],"rPFS.":[108],"Methods:":[109],"Before":[110],"randomization,":[111],"tumor":[112,140,221],"samples":[113],"(":[114,282],">":[115],"90%":[116],"archival)":[117],"were":[118,158,186],"tested":[119],"VENTANA":[124],"(SP218)":[126],"IHC":[127,146,152,212,280],"assay":[128,171],"(N":[129],"1101).":[131],"pre-defined":[135],"\u2265":[137,219,232,240,248],"50%":[138,284],"of":[139,181,338,354,360],"cells":[141,222],"no":[143,285,348],"specific":[144],"cytoplasmic":[145],"staining.":[147],"Exploratory":[148],"analysis":[149],"evaluated":[150],"different":[151],"staining":[153],"cutoffs.":[154],"Tumor":[155],"genomic":[156,330],"alterations":[157,331,350],"profiled":[159],"next-generation":[161],"sequencing":[162],"(NGS)":[163],"using":[164],"Foundation":[166],"Medicine":[167],"FoundationOne":[168],"CDx":[169],"NGS":[170,320],"(Shi,":[172],"ASGO-GU":[173],"2020;":[174],"n":[175,183],"743":[177],"evaluable":[178],"NGS,":[180],"which":[182],"518":[185],"evaluable).":[188],"rPFS":[189,273,296,339],"determined":[191],"investigator.":[194],"Results:":[195],"Consistent":[196],"benefit":[197,340],"combination":[200],"arm":[201],"observed":[207],"when":[208],"defined":[214],"more":[215],"stringently":[216],"(rPFS":[217],"at":[218],"60%":[220],"loss:":[225],"0.72":[227,235,251],"CI,":[229,237,245,253,260],"0.56,":[230,238],"0.92];":[231,247],"70%:":[233],"0.93];":[239],"80%:":[241],"0.71":[243],"0.54,":[246],"90%:":[249],"0.53,":[254],"0.97];":[255],"100%:":[256],"0.65":[258],"0.39,":[261],"1.08]).":[262],"contrast,":[264],"associated":[270,357],"improved":[272],"pts":[275,322,346],"intact":[278],"<":[283],"staining;":[286],"stratified":[287],"0.91":[289],"0.72,":[292],"1.16]);":[293],"19.1":[298],"16.4,":[302,313],"21.9)":[303],"19.7":[309],"26.3)":[314],"By":[319],"assessment,":[321],"PIK3CA/AKT1/PTEN":[333],"had":[334],"a":[335,370,380,384],"larger":[336],"magnitude":[337],"than":[345],"detectable":[349],"(Table).":[351],"Conclusions:":[352],"Analyses":[353],"more-stringent":[355],"biomarkers":[356],"activation":[359],"PI3K/AKT":[362,377],"pathway":[363,378],"further":[364],"support":[365],"option":[372],"mCRPC":[375,381],"alterations,":[379],"subtype":[382],"worse":[385],"prognosis.":[386],"Clinical":[387],"trial":[388],"information:":[389],"NCT03072238.":[390],"[Table:":[391],"see":[392],"text]":[393]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-15T00:00:00"}